Counteracting Learned Non-use Through Augmented Visuomotor Feedback in Virtual Reality (RGS)

January 14, 2016 updated by: Paul Verschure, Universitat Pompeu Fabra

Desaprendiendo la parálisis Aprendida Con RGS en Pacientes Afectos de Ictus

The purpose of this study is to determine if Reinforcement-Induced Movement Therapy (RIMT), a novel rehabilitation method that augments visuomotor feedback of movements of the patient in virtual reality, is effective in treating hemiparesis resp. learned non-use.

Study Overview

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Mild-to-moderate upper-limbs hemiparesis (Proximal Medical Research Council Scale > 2) due to ischemic or hemorrhagic stroke
  • Spasticity in the affected limb (Modified Ashworth Scale <3)
  • First-ever ischemic or hemorrhagic stroke (>4 weeks post-stroke)
  • Sufficient cognitive capacity for following the instruction of the intervention (Mini-Mental State Evaluation >24)

Exclusion Criteria:

  • Cognitive impairment that impede the correct execution or understanding of the intervention
  • Severe impairments in vision or visual perception abilities (such as vision loss or spatial neglect), in spasticity, in communication abilities (such as aphasia or apraxia), severe pain as well as other neuromuscular or orthopedic changes that impede the correct execution of the intervention training
  • Mental dysfunctioning during the acute or subacute phase after the stroke.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
Virtual reality based therapy with augmented visuomotor feedback.
6 weeks, 1 session a day, 30min per sessions, of physical therapy using a VR rehabilitation gaming system (RGS) with augmented visuomotor feedback
Other Names:
  • VR-based motor rehabilitation in RGS with amplified visuomotor feedback
Active Comparator: Control Group
Virtual reality based therapy without augmentation.
6 weeks, 1 session a day, 30min per sessions, of physical therapy using a VR rehabilitation gaming system (RGS)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The upper extremity Fugl-Meyer Assessment
Time Frame: at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
change from baseline in motor function
at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chedoke Arm Hand Inventory
Time Frame: at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
change from baseline in functional recovery
at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
Barthel Index
Time Frame: at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
change from baseline in activities of daily living
at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
Hamilton Scale
Time Frame: at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up
change from baseline in measurement of depression
at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rosa Maria San Segundo Mozo, Dra., Medico Especialista en Medician Fisica y Rehabilitation, Doctora por al Universitat Rovira i Virgili de Tarragona
  • Study Director: Paul F.M.J. Verschure, Prof., Director SPECS

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

August 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

January 13, 2016

First Submitted That Met QC Criteria

January 14, 2016

First Posted (Estimate)

January 15, 2016

Study Record Updates

Last Update Posted (Estimate)

January 15, 2016

Last Update Submitted That Met QC Criteria

January 14, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • CEIC 53/2013

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemiparesis

Clinical Trials on Reinforcement-Induced Movement Therapy (RIMT)

3
Subscribe